166 related articles for article (PubMed ID: 34883306)
1. Development and external validation of a prediction model for tube feeding dependency for at least four weeks during chemoradiotherapy for head and neck cancer.
Willemsen ACH; Kok A; Baijens LWJ; de Boer JP; de Bree R; Devriese LA; Driessen CML; van Herpen CML; Hoebers FJP; Kaanders JHAM; Karsten RT; van Kuijk SMJ; Lalisang RI; Navran A; Pereboom SR; Schols AMWJ; Terhaard CHJ; Hoeben A
Clin Nutr; 2022 Jan; 41(1):177-185. PubMed ID: 34883306
[TBL] [Abstract][Full Text] [Related]
2. Prediction model for tube feeding dependency during chemoradiotherapy for at least four weeks in head and neck cancer patients: A tool for prophylactic gastrostomy decision making.
Willemsen ACH; Kok A; van Kuijk SMJ; Baijens LWJ; de Bree R; Devriese LA; Hoebers FJP; Lalisang RI; Schols AMWJ; Terhaard CHJ; Hoeben A
Clin Nutr; 2020 Aug; 39(8):2600-2608. PubMed ID: 31839429
[TBL] [Abstract][Full Text] [Related]
3. From reactive to proactive tube feeding during chemoradiotherapy for head and neck cancer: A clinical prediction model-based approach.
Karsten RT; Stuiver MM; van der Molen L; Navran A; de Boer JP; Hilgers FJM; Klop WMC; Smeele LE
Oral Oncol; 2019 Jan; 88():172-179. PubMed ID: 30616790
[TBL] [Abstract][Full Text] [Related]
4. Disease-induced and treatment-induced alterations in body composition in locally advanced head and neck squamous cell carcinoma.
Willemsen ACH; Hoeben A; Lalisang RI; Van Helvoort A; Wesseling FWR; Hoebers F; Baijens LWJ; Schols AMWJ
J Cachexia Sarcopenia Muscle; 2020 Feb; 11(1):145-159. PubMed ID: 31536685
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Nutritional and Clinical Outcomes in Patients with Head and Neck Cancer Undergoing Chemoradiotherapy Utilizing Prophylactic versus Reactive Nutrition Support Approaches.
Brown TE; Banks MD; Hughes BGM; Lin CY; Kenny LM; Bauer JD
J Acad Nutr Diet; 2018 Apr; 118(4):627-636. PubMed ID: 27986517
[TBL] [Abstract][Full Text] [Related]
6. Predictive and prognostic value of CT based radiomics signature in locally advanced head and neck cancers patients treated with concurrent chemoradiotherapy or bioradiotherapy and its added value to Human Papillomavirus status.
Ou D; Blanchard P; Rosellini S; Levy A; Nguyen F; Leijenaar RTH; Garberis I; Gorphe P; Bidault F; Ferté C; Robert C; Casiraghi O; Scoazec JY; Lambin P; Temam S; Deutsch E; Tao Y
Oral Oncol; 2017 Aug; 71():150-155. PubMed ID: 28688683
[TBL] [Abstract][Full Text] [Related]
7. Enteral feeding in head and neck cancer patients at a UK cancer centre.
Sheth CH; Sharp S; Walters ER
J Hum Nutr Diet; 2013 Oct; 26(5):421-8. PubMed ID: 23379517
[TBL] [Abstract][Full Text] [Related]
8. Gastrostomy dependency trends over 15 years of patients at a large tertiary referral center following the insertion of a prophylactic gastrostomy for chemoradiation for mucosal head and neck cancer.
Fraser A; Odelli C; Britton B; Kumar M; Day F; Tieu MT; Wratten C
Asia Pac J Clin Oncol; 2020 Oct; 16(5):e198-e206. PubMed ID: 32519509
[TBL] [Abstract][Full Text] [Related]
9. Distinctive mucositis and feeding-tube dependency in cetuximab plus radiotherapy for head and neck cancer.
Yokota T; Onoe T; Ogawa H; Hamauchi S; Iida Y; Kamijo T; Suda T; Yurikusa T; Nishimura T; Yasui H; Onitsuka T
Jpn J Clin Oncol; 2015 Feb; 45(2):183-8. PubMed ID: 25420692
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors for tube feeding dependence after curative (chemo-) radiation in head and neck cancer: A systematic review of literature.
Wopken K; Bijl HP; Langendijk JA
Radiother Oncol; 2018 Jan; 126(1):56-67. PubMed ID: 28943045
[TBL] [Abstract][Full Text] [Related]
11. Gastrostomy versus nasogastric tube feeding for chemoradiation patients with head and neck cancer: the TUBE pilot RCT.
Paleri V; Patterson J; Rousseau N; Moloney E; Craig D; Tzelis D; Wilkinson N; Franks J; Hynes AM; Heaven B; Hamilton D; Guerrero-Urbano T; Donnelly R; Barclay S; Rapley T; Stocken D
Health Technol Assess; 2018 Apr; 22(16):1-144. PubMed ID: 29650060
[TBL] [Abstract][Full Text] [Related]
12. A Predictive Model for Reactive Tube Feeding in Head and Neck Cancer Patients Undergoing Definitive (Chemo) Radiotherapy.
Gaito S; France A; Foden P; Abravan A; Burnet N; Garcez K; Kota VR; Lee LW; Price J; Sykes A; Thomson D; Smith E; Osorio EV; McPartlin A
Clin Oncol (R Coll Radiol); 2021 Oct; 33(10):e433-e441. PubMed ID: 34090753
[TBL] [Abstract][Full Text] [Related]
13. A prospective study comparing prophylactic gastrostomy to nutritional counselling with a therapeutic feeding tube if required in head and neck cancer patients undergoing chemoradiotherapy in Thai real-world practice.
Pramyothin P; Manyanont S; Trakarnsanga A; Petsuksiri J; Ithimakin S
J Hum Nutr Diet; 2016 Dec; 29(6):768-776. PubMed ID: 27028666
[TBL] [Abstract][Full Text] [Related]
14. Tooth extractions prior to chemoradiation or bioradiation are associated with weight loss during treatment for locally advanced oropharyngeal cancer.
Buurman DJM; Willemsen ACH; Speksnijder CM; Baijens LWJ; Hoeben A; Hoebers FJP; Kessler P; Schols AMWJ
Support Care Cancer; 2022 Jun; 30(6):5329-5338. PubMed ID: 35278135
[TBL] [Abstract][Full Text] [Related]
15. Pretreatment predictive factors for feasibility of oral intake in adjuvant concurrent chemoradiotherapy for patients with locally advanced squamous cell carcinoma of the head and neck.
Kimura H; Hamauchi S; Kawai S; Onozawa Y; Yasui H; Yamashita A; Ogawa H; Onoe T; Kamijo T; Iida Y; Onitsuka T; Yokota T
Int J Clin Oncol; 2020 Feb; 25(2):258-266. PubMed ID: 31620932
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic gastrostomy in locally advanced head and neck cancer: results of a national survey among radiation oncologists.
Dragan T; Duprez F; Van Gossum A; Gulyban A; Beauvois S; Digonnet A; Lalami Y; Van Gestel D
BMC Cancer; 2021 Jun; 21(1):656. PubMed ID: 34078309
[TBL] [Abstract][Full Text] [Related]
17. Early Loss of Fat Mass During Chemoradiotherapy Predicts Overall Survival in Locally Advanced Squamous Cell Carcinoma of the Lung, but Not in Locally Advanced Squamous Cell Carcinoma of the Head and Neck.
Willemsen ACH; Degens JHRJ; Baijens LWJ; Dingemans AC; Hoeben A; Hoebers FJP; De Ruysscher DKM; Schols AMWJ
Front Nutr; 2020; 7():600612. PubMed ID: 33324671
[No Abstract] [Full Text] [Related]
18. Nutritional management in head and neck cancer: United Kingdom National Multidisciplinary Guidelines.
Talwar B; Donnelly R; Skelly R; Donaldson M
J Laryngol Otol; 2016 May; 130(S2):S32-S40. PubMed ID: 27841109
[TBL] [Abstract][Full Text] [Related]
19. Enteral tube feeding of head and neck cancer patients undergoing definitive chemoradiotherapy in the Nordic Countries: Survey of the Scandinavian Society for Head and Neck Oncology.
Ilmarinen T; Hammarstedt-Nordenvall L; Bäck L; Mäkitie A
Eur Arch Otorhinolaryngol; 2021 Sep; 278(9):3489-3496. PubMed ID: 33389006
[TBL] [Abstract][Full Text] [Related]
20. A multicenter phase II trial of paclitaxel, carboplatin, and cetuximab followed by chemoradiotherapy in patients with unresectable locally advanced squamous cell carcinoma of the head and neck.
Enokida T; Ogawa T; Homma A; Okami K; Minami S; Nakanome A; Shimizu Y; Maki D; Ueda Y; Fujisawa T; Motegi A; Ohkoshi A; Taguchi J; Ebisumoto K; Nomura S; Okano S; Tahara M
Cancer Med; 2020 Mar; 9(5):1671-1682. PubMed ID: 31943834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
